Company Overview
CITIUS PHARMACEUTICALS, INC.
CTXRRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
—M
2025 FY
Net Income
-40M
2025 FY
Shares Outstanding
11M
2025 FY
EPS
-3.38USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1506251
Exchange
Nasdaq
Location
US